Aveanna Healthcare (AVAH) Competitors

$7.33 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$7.50 +0.18 (+2.39%)

As of 05/22/2026 06:31 PM Eastern

AVAH vs. CELC, PACS, HIMS, SHC, and CAI

Should you buy Aveanna Healthcare stock or one of its competitors? MarketBeat compares Aveanna Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aveanna Healthcare include Celcuity (CELC), PACS Group (PACS), Hims & Hers Health (HIMS), Sotera Health (SHC), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does Aveanna Healthcare compare to Celcuity?

Celcuity (NASDAQ:CELC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

In the previous week, Aveanna Healthcare had 9 more articles in the media than Celcuity. MarketBeat recorded 10 mentions for Aveanna Healthcare and 1 mentions for Celcuity. Celcuity's average media sentiment score of 0.84 beat Aveanna Healthcare's score of 0.31 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare has a net margin of 10.37% compared to Celcuity's net margin of 0.00%. Aveanna Healthcare's return on equity of 124.68% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Aveanna Healthcare	10.37%	124.68%	7.07%

Celcuity presently has a consensus target price of $149.30, suggesting a potential upside of 8.01%. Aveanna Healthcare has a consensus target price of $10.50, suggesting a potential upside of 43.25%. Given Aveanna Healthcare's higher possible upside, analysts plainly believe Aveanna Healthcare is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aveanna Healthcare has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Aveanna Healthcare	$2.43B	0.66	$225.03M	$1.18	6.21

Celcuity has a beta of 0.09, indicating that its stock price is 91% less volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, indicating that its stock price is 93% more volatile than the broader market.

Summary

Aveanna Healthcare beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to PACS Group?

PACS Group (NYSE:PACS) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

In the previous week, Aveanna Healthcare had 4 more articles in the media than PACS Group. MarketBeat recorded 10 mentions for Aveanna Healthcare and 6 mentions for PACS Group. Aveanna Healthcare's average media sentiment score of 0.31 beat PACS Group's score of 0.25 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aveanna Healthcare	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has a beta of -0.03, meaning that its share price is 103% less volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, meaning that its share price is 93% more volatile than the broader market.

88.0% of Aveanna Healthcare shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

PACS Group presently has a consensus price target of $48.00, suggesting a potential upside of 27.06%. Aveanna Healthcare has a consensus price target of $10.50, suggesting a potential upside of 43.25%. Given Aveanna Healthcare's higher probable upside, analysts plainly believe Aveanna Healthcare is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58

Aveanna Healthcare has lower revenue, but higher earnings than PACS Group. Aveanna Healthcare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.13	$191.54M	$1.56	24.22
Aveanna Healthcare	$2.43B	0.66	$225.03M	$1.18	6.21

Aveanna Healthcare has a net margin of 10.37% compared to PACS Group's net margin of 4.49%. Aveanna Healthcare's return on equity of 124.68% beat PACS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Aveanna Healthcare	10.37%	124.68%	7.07%

Summary

Aveanna Healthcare beats PACS Group on 10 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

In the previous week, Hims & Hers Health had 24 more articles in the media than Aveanna Healthcare. MarketBeat recorded 34 mentions for Hims & Hers Health and 10 mentions for Aveanna Healthcare. Hims & Hers Health's average media sentiment score of 0.33 beat Aveanna Healthcare's score of 0.31 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	11 Very Positive mention(s)	2 Positive mention(s)	14 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral
Aveanna Healthcare	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.30	$128.37M	-$0.09	N/A
Aveanna Healthcare	$2.43B	0.66	$225.03M	$1.18	6.21

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.37% compared to Hims & Hers Health's net margin of -0.56%. Aveanna Healthcare's return on equity of 124.68% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Aveanna Healthcare	10.37%	124.68%	7.07%

Hims & Hers Health has a beta of 2.43, meaning that its stock price is 143% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

Hims & Hers Health currently has a consensus target price of $28.90, suggesting a potential upside of 21.88%. Aveanna Healthcare has a consensus target price of $10.50, suggesting a potential upside of 43.25%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58

Summary

Aveanna Healthcare beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Sotera Health has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

Sotera Health currently has a consensus target price of $20.33, indicating a potential upside of 29.84%. Aveanna Healthcare has a consensus target price of $10.50, indicating a potential upside of 43.25%. Given Aveanna Healthcare's higher probable upside, analysts clearly believe Aveanna Healthcare is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58

In the previous week, Aveanna Healthcare had 4 more articles in the media than Sotera Health. MarketBeat recorded 10 mentions for Aveanna Healthcare and 6 mentions for Sotera Health. Aveanna Healthcare's average media sentiment score of 0.31 beat Sotera Health's score of -0.02 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aveanna Healthcare	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare has higher revenue and earnings than Sotera Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.84	$77.94M	$0.41	38.20
Aveanna Healthcare	$2.43B	0.66	$225.03M	$1.18	6.21

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.37% compared to Sotera Health's net margin of 9.91%. Aveanna Healthcare's return on equity of 124.68% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Aveanna Healthcare	10.37%	124.68%	7.07%

Summary

Aveanna Healthcare beats Sotera Health on 11 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Caris Life Sciences?

Aveanna Healthcare (NASDAQ:AVAH) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Aveanna Healthcare had 2 more articles in the media than Caris Life Sciences. MarketBeat recorded 10 mentions for Aveanna Healthcare and 8 mentions for Caris Life Sciences. Aveanna Healthcare's average media sentiment score of 0.31 beat Caris Life Sciences' score of 0.18 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Caris Life Sciences	0 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare presently has a consensus price target of $10.50, indicating a potential upside of 43.25%. Caris Life Sciences has a consensus price target of $27.56, indicating a potential upside of 77.21%. Given Caris Life Sciences' higher possible upside, analysts plainly believe Caris Life Sciences is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58
Caris Life Sciences	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Aveanna Healthcare has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	0.66	$225.03M	$1.18	6.21
Caris Life Sciences	$812.03M	5.41	-$68.09M	-$7.61	N/A

Aveanna Healthcare has a net margin of 10.37% compared to Caris Life Sciences' net margin of 3.75%. Aveanna Healthcare's return on equity of 124.68% beat Caris Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.37%	124.68%	7.07%
Caris Life Sciences	3.75%	98.28%	48.87%

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 7.8% of Caris Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Aveanna Healthcare beats Caris Life Sciences on 11 of the 16 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVAH vs. The Competition

Export

Metric	Aveanna Healthcare	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.60B	$5.62B	$6.45B	$12.34B
Dividend Yield	N/A	1.53%	2.76%	5.28%
P/E Ratio	6.21	31.31	21.22	25.65
Price / Sales	0.66	24.25	553.92	86.28
Price / Cash	10.63	16.19	43.49	56.67
Price / Book	6.66	3.08	10.37	7.14
Net Income	$225.03M	$218.81M	$3.57B	$335.98M
7 Day Performance	-4.81%	-0.34%	6.01%	3.56%
1 Month Performance	11.91%	0.60%	3.52%	2.54%
1 Year Performance	37.78%	16.17%	34.13%	35.05%

Aveanna Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVAH Aveanna Healthcare	4.9046 of 5 stars	$7.33 flat	$10.50 +43.2%	+37.8%	$1.60B	$2.43B	6.21	35,500	Gap Up
CELC Celcuity	2.0858 of 5 stars	$131.76 -0.3%	$149.30 +13.3%	+1,224.0%	$6.42B	N/A	N/A	40
PACS PACS Group	3.9258 of 5 stars	$36.65 -0.4%	$48.00 +31.0%	+285.9%	$5.79B	$5.29B	23.43	47,455	Positive News
HIMS Hims & Hers Health	4.3018 of 5 stars	$22.43 +0.6%	$29.37 +30.9%	-56.8%	$5.13B	$2.35B	N/A	2,442	Analyst Forecast Gap Down
SHC Sotera Health	3.691 of 5 stars	$15.22 -0.9%	$20.33 +33.6%	+28.8%	$4.34B	$1.16B	37.11	3,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aveanna Healthcare (AVAH) Competitors

AVAH vs. CELC, PACS, HIMS, SHC, and CAI

How does Aveanna Healthcare compare to Celcuity?

Summary

How does Aveanna Healthcare compare to PACS Group?

Summary

How does Aveanna Healthcare compare to Hims & Hers Health?

Summary

How does Aveanna Healthcare compare to Sotera Health?

Summary

How does Aveanna Healthcare compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aveanna Healthcare (AVAH) Competitors

AVAH vs. CELC, PACS, HIMS, SHC, and CAI

How does Aveanna Healthcare compare to Celcuity?

Does the media refer more to CELC or AVAH?

Is CELC or AVAH more profitable?

Do analysts recommend CELC or AVAH?

Do insiders & institutionals hold more shares of CELC or AVAH?

Which has preferable valuation and earnings, CELC or AVAH?

Which has more volatility and risk, CELC or AVAH?

Summary

How does Aveanna Healthcare compare to PACS Group?

Does the media favor PACS or AVAH?

Which has more volatility & risk, PACS or AVAH?

Do insiders and institutionals have more ownership in PACS or AVAH?

Do analysts recommend PACS or AVAH?

Which has better valuation and earnings, PACS or AVAH?

Is PACS or AVAH more profitable?

Summary

How does Aveanna Healthcare compare to Hims & Hers Health?

Does the media refer more to HIMS or AVAH?

Which has preferable earnings & valuation, HIMS or AVAH?

Do insiders & institutionals have more ownership in HIMS or AVAH?

Is HIMS or AVAH more profitable?

Which has more risk and volatility, HIMS or AVAH?

Do analysts prefer HIMS or AVAH?

Summary

How does Aveanna Healthcare compare to Sotera Health?

Which has more risk & volatility, SHC or AVAH?

Do analysts prefer SHC or AVAH?

Does the media refer more to SHC or AVAH?

Which has stronger earnings & valuation, SHC or AVAH?

Do insiders and institutionals believe in SHC or AVAH?

Is SHC or AVAH more profitable?

Summary

How does Aveanna Healthcare compare to Caris Life Sciences?

Does the media favor AVAH or CAI?

Do analysts prefer AVAH or CAI?

Which has better valuation & earnings, AVAH or CAI?

Is AVAH or CAI more profitable?

Do insiders & institutionals believe in AVAH or CAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools